Enforcement
-
AI enforcement accelerates as federal policy stalls and states step in
This article examines the evolving federal and state AI enforcement landscape and outlines practical considerations for companies deploying AI technologies.
-
GRIP Extra: OSFI releases Annual Risk Outlook, SEC advances Treasury cash futures cross margining
Our in-brief roundup of notable stories from the last week.
-
Three March SEC cases highlight investor protection
A brief enforcement roundup.
-
Podiatrist, pharma rep sentenced to 63 months for healthcare fraud
In a case involving an unlicensed person performing medical procedures on unwitting patients, the two California men billed state and federal programs $3.2m in false claims.
-
FDA targets companies marketing unapproved weight‑loss drugs online
The FDA’s latest round of warning letters points to an intensifying regulatory trend targeting companies marketing and selling GLP-1 and related compounds online.
-
What the ECJ’s landmark ruling on defective products liability means for life sciences manufacturers
This article covers the expanded litigation risk, the steps life science companies should take to reinforce their product safety, and risk‑management governance.
-
Asia-Pacific in focus: March 2026 at a glance
Our March 2026 roundup from the financial regulation industries across the Asia-Pacific region.
-
FCA work in review: March 30-April 10, 2026
Our regular roundup of the latest news and developments from the FCA.